Patent status
Based on the intellectual property documents currently available, no granted patent or published application specifically naming Eyevistar® has been documented.
Granted patents
| Patent No. | Territory | Title | Grant year |
|---|---|---|---|
| No Eyevistar®-specific granted patent currently verified | Not available | Not available | Not available |
The current Star Hi Herbs patent register includes intellectual property records for brands and product families such as Turmimax™, Forcslim™, Storg®, Cissuslean® and Bacosane®. Eyevistar® is not currently listed in the patent register.
Patent numbers, territories, titles and grant dates will be added only after confirmation by the Star Hi Herbs intellectual property or legal team.
What the available documentation supports
- Standardized composition: marigold-derived lutein at 20% and zeaxanthin at 4%
- Retinal cell application: evaluated in ARPE-19 cells under UV-induced oxidative stress
- A2E and lipofuscin modulation: reductions in UV-induced accumulation
- Retinal bioavailability: dose-dependent restoration of lutein and zeaxanthin in plasma and macular tissue
- Retinal protection: histopathology and TEM indicated preserved retinal architecture
Documentation note
Patent status updates
Star Hi Herbs will update this page when verified Eyevistar® patent information becomes available, including patent or application number, filing and grant territory, official patent title, filing or grant date and claim scope.
Request verified IP documentation
Our team can share the current intellectual property position for Eyevistar® under confidentiality.